Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations

Michelangelo Marasco(Memorial Sloan Kettering Cancer Center), Sandra Misale(IFOM)
Cancer Discovery
April 28, 2025
Cited by 10


Related Papers